Skip to content
HowShorted

Biocept, Inc. short interest in 2019

In 2019, Biocept, Inc.'s disclosed short interest ran from 23.97% of shares outstanding on 15 Jan 2019 to 8.92% on 13 Dec 2019, a change of -15.05 percentage points. The year's high was 48.21% on 31 Jan 2019 and its low 2.60% on 13 Sep 2019, averaging 8.92% across 21 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 3.78 days on 29 Nov 2019. Full history: Biocept, Inc..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023

Aggregate net short position time series for Biocept, Inc. in 2019

2019 in figures

Start of year
23.97% (15 Jan 2019)
End of year
8.92% (13 Dec 2019)
Change
-15.05 pp
High
48.21% (31 Jan 2019)
Low
2.60% (13 Sep 2019)
Average
8.92%
Highest days to cover
3.78 (29 Nov 2019)
SEC filings marked
8

Every report in 2019

Biocept, Inc. short interest in 2019
SettlementShort interestDays to coverFilings since previous
15 Jan 201923.97%1.00
31 Jan 201948.21%1.00
15 Mar 201921.26%1.00
29 Mar 20196.03%1.0010-K filed, results (8-K)
15 Apr 20196.64%1.26
30 Apr 20194.37%1.12
15 May 20195.27%1.36results (8-K), 10-Q filed
31 May 201911.83%1.00
14 Jun 20194.87%1.00
28 Jun 20194.06%1.00
15 Jul 20193.71%1.63
31 Jul 20193.55%1.37
15 Aug 20193.14%1.17results (8-K), 10-Q filed
30 Aug 20193.09%1.97
13 Sep 20192.60%1.73
30 Sep 20192.90%2.26
15 Oct 20192.90%2.49
31 Oct 20192.80%2.42
15 Nov 20197.40%2.8010-Q filed, results (8-K)
29 Nov 20199.70%3.78
13 Dec 20198.92%1.00

See also: Biocept, Inc.'s full history · most shorted US stocks of 2019 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.